MR编号 | SE/H/0481/003 |
---|
药品名称 | Fosrenol |
---|
活性成分 | - lanthanum(III)carbonate 750.0 mg
|
---|
剂型 | Chewable tablet |
---|
上市许可持有人 | Takeda Pharmaceuticals International AG Ireland Branch |
---|
参考成员国 - 产品名称 | Sweden (SE) |
---|
互认成员国 - 产品名称 | - Italy (IT)
- Greece (GR)
- Norway (NO)
- Finland (FI)
- Latvia (LV)
- Estonia (EE)
FOSRENOL - Hungary (HU)
FOSRENOL 750 mg rágótabletta - Bulgaria (BG)
Fosrenol - Cyprus (CY)
- Slovakia (SK)
Fosrenol 750 mg žuvacie tablety - Slovenia (SI)
- Malta (MT)
- Lithuania (LT)
FOSRENOL 750 mg kramtomosios tabletės - Germany (DE)
- Denmark (DK)
- Belgium (BE)
- Netherlands (NL)
- Luxembourg (LU)
- Iceland (IS)
- Ireland (IE)
- Austria (AT)
Fosrenol 750 mg Kautabletten - France (FR)
|
---|
许可日期 | 2005/03/01 |
---|
最近更新日期 | 2024/12/12 |
---|
药物ATC编码 | - V03AE03 lanthanum carbonate
|
---|
申请类型 | - TypeLevel1:New Active Substance
- TypeLevel2:Additional Strength/Form
- TypeLevel3:Full Dossier [Article 8.3(i)]
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|